The FDA assigned INO-3107 a Prescription Drug User Fee Act (PDUFA) review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated ...
FREE Study to evaluate the efficacy and safety of ARAKODA® (tafenoquine) for treatment of chronic babesiosisData support ...
According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...
This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Discover Bank products are no longer available through this site, and content may be out of date Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. Editor's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results